SLC16A3 and neoplasm: Li and his colleague reported that ALKBH5 modulated Mct4/Slc16a3 expression and lactate content of the tumor microenvironment and promoted the composition of tumor-infiltrating Treg and myeloid-derived suppressor cells in melanoma and colorectal cancer, thus leading to resistance to immunotherapy.